Abstract: Disclosed is an elevator system, including a hoistway; an elevator car in the hoistway; sensors in the hoistway operationally coupled to the elevator car and configured to capture sensor data indicative of a person being in the hoistway, and a processor configured to determine from the sensor data that the person is in the hoistway; and wherein the elevator car is configured to reduce speed or stop when the processor determines the person is in the hoistway.

Abstract: The invention relates to endovascular medical implant devices and materials of composition for forming these devices to provide improved mechanical properties and biodegradability. The devices include a combination or integration of superelastic material, biodegradable metal and, thin film nitinol and/or biodegradable polymer. A structural frame is formed of individual elongated pieces composed of biodegradable metal. These pieces are joined together by connector pieces composed of superelastic material. At least a portion of the structural frame has deposited thereon the thin film nitinol and/or biodegradable polymer. The structural frame of the device is collapsible for insertion in a delivery tube and, recoverable for deployment and placement in a vascular location of a patient body.

Abstract: A system for lung assist includes a plurality of fiber bundle sections. Each of the fiber bundle sections includes a fiber bundle housing defining a fiber bundle compartment therein and a fiber bundle positioned within the fiber bundle compartment. The fiber bundle includes a plurality of hollow gas permeable fibers configured to permit diffusion of gas between blood and an interior of the plurality of hollow gas permeable fibers. The plurality of hollow gas permeable fibers is positioned such that blood flows around the plurality of hollow gas permeable fibers when flowing through the fiber bundle compartment. Each fiber bundle is different in at least one property from each other fiber bundle.

Abstract: A system for lung assist includes a plurality of fiber bundle sections which includes a fiber bundle housing defining a fiber bundle compartment with a fiber bundle positioned within. The fiber bundle includes a plurality of hollow gas permeable fibers. The fiber bundle housing further includes a gas inlet in fluid connection with the fiber bundle housing and in fluid connection with inlets of the plurality of hollow gas permeable fibers, a gas outlet in fluid connection with the housing and in fluid connection with outlets of the plurality of hollow gas permeable fibers, and a blood outlet in fluid connection with a first end of the fiber bundle. The system further includes a base section including a housing including a pressurizing compartment, a pressurizing mechanism within the pressurizing compartment, a blood inlet in fluid connection with the pressurizing compartment and a conduit.

Abstract: The invention relates to endovascular medical implant devices and materials of composition for forming these devices to provide improved mechanical properties and biodegradability. The devices include a combination or integration of superelastic material, biodegradable metal and, thin film nitinol and/or biodegradable polymer. A structural frame is formed of individual elongated pieces composed of biodegradable metal. These pieces are joined together by connector pieces composed of superelastic material. At least a portion of the structural frame has deposited thereon the thin film nitinol and/or biodegradable polymer. The structural frame of the device is collapsible for insertion in a delivery tube and, recoverable for deployment and placement in a vascular location of a patient body.

Abstract: The invention relates to endovascular medical implant devices and materials of composition for forming these devices to provide improved mechanical properties and biodegradability. The devices include a combination or integration of superelastic material, biodegradable metal and, thin film nitinol and/or biodegradable polymer. A structural frame is formed of individual elongated pieces composed of biodegradable metal. These pieces are joined together by connector pieces composed of superelastic material. At least a portion of the structural frame has deposited thereon the thin film nitinol and/or biodegradable polymer. The structural frame of the device is collapsible for insertion in a delivery tube and, recoverable for deployment and placement in a vascular location of a patient body.

Abstract: A method for determining a power reduction due to ageing of a photovoltaic module includes measuring a variable associated with a performance of the module in one or more time periods within a given year, each time period defining a class, and constructing curves of discrete values, each power curve constructed from the measured electric variable at a plurality of times of a day within each class, and the curves constructed for a plurality of years. The method includes determining energy values based on the constructed curves for at least one class for each of the plurality of years, and determining a power reduction of the photovoltaic module with respect to one or several previous years by calculating a difference between the energy output values of a given class in a particular year and the energy output values of the given class in a year previous to the particular year.

Abstract: A query engine for integrating authorization conditions within a database query statement. The query engine may include an authorization handler configured to receive authorization parameters related to one or more authorization objects for data relevant to a query for performing an authority check, and obtain at least one user authorization profile for a current user based on the authorization parameters. The at least one user authorization profile may include an activity value and one or more authorization conditions associated with the activity value. The query engine may further include a query generator configured to receive query parameters related to the query and integrate the query parameters with the one or more authorization conditions to obtain a database query statement, and a database selector configured to obtain authorized data from an in-memory database based on the database query statement.

Abstract: A power generation system for feeding power from generators into an AC grid, the system comprising a plurality of inverters connected to corresponding ones of the generators, and connected to the AC grid is disclosed. The plurality of inverters forms part of a data network, wherein one of the inverters forms a communication unit for receiving feed-in parameters from a grid control system and for controlling the plurality of inverters via the data network such that the power generation system feeds power to the AC grid in accordance with the feed-in parameters.

Abstract: A method for determining a power reduction due to ageing of a photovoltaic module includes measuring a variable associated with a performance of the module in one or more time periods within a given year, each time period defining a class, and constructing curves of discrete values, each power curve constructed from the measured electric variable at a plurality of times of a day within each class, and the curves constructed for a plurality of years. The method includes determining energy values based on the constructed curves for at least one class for each of the plurality of years, and determining a power reduction of the photovoltaic module with respect to one or several previous years by calculating a difference between the energy output values of a given class in a particular year and the energy output values of the given class in a year previous to the particular year.

Abstract: A power generation system for feeding power from generators into an AC grid, the system comprising a plurality of inverters connected to corresponding ones of the generators, and connected to the AC grid is disclosed. The plurality of inverters forms part of a data network, wherein one of the inverters forms a communication unit for receiving feed-in parameters from a grid control system and for controlling the plurality of inverters via the data network such that the power generation system feeds power to the AC grid in accordance with the feed-in parameters.

Abstract: The invention is directed to an evaluation method for determining a power reduction due to ageing of at least one photovoltaic module at constant radiation intensity with a measurement of an electric variable that may change after a period of time such as cell current, cell voltage and/or cell power, without additional sensors for measuring the radiation intensity, with the following steps fixing at least one class k that can be compared year by year and within which a daily power curve or portions of the daily power curve of the photovoltaic module can be compared to each other due to the radiation intensity and the outside temperature to be expected as well as the radiation time, the class k corresponding to a defined period of a year, measuring energy output values Ek,n that can be compared year by year from a comparable power curve Pk,n (t) through the variable delivered by the photovoltaic generator so that energy differences are determined on the basis of the classes k, n being the respective year, i

Abstract: A process for the preparation of a pharmaceutical composition in the form of agglomerates comprising 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a pharmaceutically acceptable salt thereof and 3-30% by weight of a starch component, said process comprising the steps of a) forming an emulsion comprising 1) 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a salt thereof 2) a solvent system 3) 3-30% by weight of the starch component 4) water and optionally 5) a surfactant b) crystallising to produce a suspension comprising crystals of 2-(4-isobutylphenyl)propionic acid or the salt thereof in intimate contact with the starch component c) agitating said suspension to form agglomerates comprising an evenly distributed mixture of 2-(4-isobutylphenyl)propionic acid or a salt thereof and the starch component d) collecting said agglomerates and optionally e) drying said agglomerates. Pharmaceutical formulations comprising 90-99.98% by weight of such a composition together with 0.